170
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice

&
Pages 831-838 | Received 13 Feb 2014, Accepted 09 Apr 2015, Published online: 26 May 2015

REFERENCES

  • Cruz-Correa M and Giardiello FM: Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am 31, 537–549, 2002.
  • Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87, 159–170, 1996.
  • Whanger PD: Selenium and its relationship to cancer: an update. Br J Nutr 91, 11–28. 2004.
  • Meyer F, Galan P, Douville P, Bairati I, Kegle P, et al.: Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 116, 182–186. 2005.
  • Amaral AF, Cantor KP, Silverman DT, and Malats N: Selenium and Bladder Cancer Risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19, 2407–2415, 2010.
  • Ip C: Lessons from basic research in selenium and cancer prevention. J Nutr 128, 1845–1854, 1998.
  • Combs GF Jr: Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 135, 343–347, 2005.
  • Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957–1963, 1996.
  • Lippman SM, Klein EA, Goodman PJ, Lucia S, Thompson IM, et al.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51, 2009.
  • Rayman MP, Combs GF Jr, and Waters DJ: Selenium and vitamin E supplementation for cancer prevention. JAMA 301, 1876, 2009.
  • L'Abbé MR, Fischer PW, Campbell JS, and Chavez ER: Effects of dietary selenium on DMBA-induced carcinogenesis in rats fed a diet high in mixed fats. J Nutr 119, 757–765, 1989.
  • Ip C and Sinha DK: Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake. Cancer Res 41, 31–34, 1981.
  • Finley JW and Davis CD: Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors 14, 191–196, 2001.
  • Lü JC: Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid Redox Signal 7, 1715–1727, 2005.
  • Zeng H and Combs GF Jr: Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19, 1–7, 2008.
  • Li GX, Lee HJ, Wang Z, Hu H, Liao JD, et al.: Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29, 1005–1012, 2008.
  • Gunter MJ and Leitzmann MF: Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 17, 145–156, 2006.
  • Jackson MI and Combs GF Jr: Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 11, 718–726, 2008.
  • Rayman MP: Selenium and human health. Lancet 379, 1256–1268, 2012.
  • Rodríguez-Ruiz J, Belarbi EH, Sánchez JLG, and Alonso DL: Rapid simultaneous lipid extraction and transesterification for fatty acid analyses. Biotechnology Techniques 12, 689–691, 1998.
  • Zhang M, Yao Z, Dubois S, Ju W, Müller JR, et al.: Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci U S A 106, 7513–7518, 2009.
  • Zeng H, Wu M, and Botnen JH: Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J Nutr 139, 1613–1618, 2009.
  • Zeng H, Yan L, Cheng WH, and Uthus EO: Dietary selenomethionine increases exon-specific DNA methylation of the p53 gene in rat liver and colon mucosa. J Nutr 141, 1464–1468, 2011.
  • Yan L, Graef GL, Reeves PG, and Johnson LK: Selenium bioavailability from soy protein isolate and tofu in rats fed a torula yeast-based diet. J Agric Food Chem 57, 11575–11580. 2009.
  • Paz-Filho G, Mastronardi C, Franco CB, Wang KB, Wong ML, et al.: Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metabol 56, 597–607, 2012.
  • Ip C and Hayes C: Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. Carcinogenesis 10, 921–925, 1989.
  • Zhuo P and Diamond AM: Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 1790, 1546–1554, 2009.
  • Whanger PD and Butler JA: Effects of various dietary levels of selenium as selenite or selenomethionine on tissue selenium levels and glutathione peroxidase activity in rats. J Nutr 118, 846–852, 1988.
  • Zeng MS, Li X, Liu Y, Zhao H, Zhou JC, et al.: A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic Biol Med 52, 1335–1342, 2012.
  • Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Bustos MJ, and Moreno-Aliaga MJ: Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta 1807, 664–678 2011.
  • Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911–919, 2005.
  • Zeng H: Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules 14, 1263–1278, 2009.
  • Zeng H, Briske-Anderson M, Wu M, and Moyer MP: Methylselenol, a selenium metabolite, plays common and different role in cancerous colon HCT116 cell and noncancerous NCM460 colon cell proliferation. Nutr Cancer 64, 128–135, 2012.
  • Li GX, Hu H, Jiang C, Schuster T, and Lü J: Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells. Int J Cancer 120, 2034–2043, 2007.
  • Porter AG and Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6, 99–104, 1999.
  • Melis MH, Simpson KL, Dovedi SJ, Welman A, Macfarlane M, et al.: Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death Differ 20, 765–773, 2013.
  • Christensen MJ: Selenium and prostate cancer prevention: what next—if anything? Cancer Prev Res 7, 781–785, 2014.
  • Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, et al.: Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial. Cancer Prev Res 7, 796–804, 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.